Related Experiment Videos
A colorimetric immunoassay based on an enzyme inhibitor method.
Journal of Immunological Methods
|July 15, 1983
Summary
A novel competitive binding immunoassay was developed for thyroxine detection. This method utilizes a thyroxine-methotrexate conjugate as a potent enzyme inhibitor, enabling colorimetric measurement of dihydrofolate reductase activity.
Area of Science:
- Biochemistry
- Immunology
- Enzyme kinetics
Background:
- Immunoassays are crucial for detecting various analytes.
- Enzyme inhibitors can be utilized in assay development.
- Dihydrofolate reductase (DHFR) is a key enzyme in folate metabolism.
Purpose of the Study:
- To develop a novel competitive binding immunoassay for thyroxine.
- To utilize an enzyme inhibitor for analyte labeling.
- To establish a colorimetric method for thyroxine quantification.
Main Methods:
- A thyroxine-methotrexate conjugate was synthesized by covalently coupling thyroxine to methotrexate.
- This conjugate acted as a potent inhibitor of dihydrofolate reductase.
- Antibody binding to the thyroxine moiety of the conjugate inactivated the inhibitor.
Main Results:
- The developed conjugate effectively inhibited dihydrofolate reductase activity.
- Antibody-bound conjugate showed reduced enzyme inhibition.
- A competitive binding immunoassay for thyroxine was successfully demonstrated.
Conclusions:
- A competitive binding immunoassay for thyroxine can be based on DHFR inhibition.
- Enzyme inhibitor labeling offers a viable strategy for immunoassay development.
- Colorimetric measurement of enzyme activity provides a sensitive detection method.